Outrage as baby dies after genital mutilation in The Gambia
The baby was rushed to a hospital in the capital, Banjiul, after she developed severe bleeding, but was pronounced dead on arrival, police said.
Although an autopsy is still being conducted to establish the cause of her death, many people have linked it to FGM, or female circumcision, a cultural practice outlawed in the West African state.
"Culture is no excuse, tradition is no shield, this is violence, pure and simple," a leading non-governmental organisation, Women In Leadership and Liberation (WILL), said in a statement.
Two women had been arrested for their alleged involvement in the baby's death, police said.
The MP for the Kombo North District where the incident happened emphasised the need to protect children from harmful practices that rob them of their health, dignity, and life.
"The loss of this innocent child must not be forgotten. Let it mark a turning-point and a moment for our nation to renew its unwavering commitment to protecting every child's right to life, safety, and dignity," Abdoulie Ceesay said.
FGM is the deliberate cutting or removal of a female's external genitalia.
The most frequently cited reasons for carrying it out are social acceptance, religious beliefs, misconceptions about hygiene, a means of preserving a girl or woman's virginity, making her "marriageable", and enhancing male sexual pleasure.
The Gambia is among the 10 countries with the highest rates of FGM, with 73% of women and girls aged 15 to 49 having undergone the procedure, with many doing so before the age of six years.
'I wanted my clitoris back' - FGM survivor
WILL founder Fatou Baldeh told the BBC that there was an increase in FGM procedures being performed on babies in The Gambia.
"Parents feel that if they cut their girls when they're babies, they heal quicker, but also, because of the law, they feel that if they perform it at such a young age, it's much easier to disguise, so that people don't know," she said.
FGM has been outlawed in The Gambia since 2015, with fines and jail terms of up to three years for perpetrators, and life sentences if a girl dies as a result.
However, there have only been two prosecutions and one conviction, in 2023.
A strong lobby group has emerged to demand the decriminalisation of FGM, but legislation aimed at repealing the ban was voted down in parliament last year.
FGM is banned in more than 70 countries globally but continues to be practised particularly in Africa's Muslim-majority countries, such as The Gambia.
You may also be interested in:
What is FGM, where does it happen and why?
FGM survivor refuses to let mutilation define her life
'Why I broke the law to be circumcised aged 26'
Go to BBCAfrica.com for more news from the African continent.
Follow us on Twitter @BBCAfrica, on Facebook at BBC Africa or on Instagram at bbcafrica
BBC Africa podcasts
Focus on Africa
This Is Africa
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
an hour ago
- Medscape
Cervical Cancer: 5 Things to Know
Cervical cancer remains a significant global health concern, ranking as the fourth most common cancer in women worldwide, with an estimated 660,000 new cases and 350,000 deaths in 2022. The burden is unevenly distributed, with over 85% of cases occurring in low- and middle-income countries, where access to preventive care and treatment is limited. In contrast, the incidence and mortality rates in the United States have declined substantially due to widespread implementation of cervical cancer screening programs and human papillomavirus (HPV) vaccination, with an estimated 13,820 new cases and 4,360 deaths expected in the US in 2024. Cervical cancer develops from a multistep transformation process triggered by persistent infection with high-risk types of HPV, most notably HPV 16 and 18. These oncogenic strains integrate into host DNA, expressing viral proteins E6 and E7, which inactivate the tumor suppressors p53 and retinoblastoma protein (Rb), respectively, and promote genomic instability. The progression from infection to cervical intraepithelial neoplasia and eventually invasive carcinoma may take 15-20 years after initial HPV infection, providing a window for early detection and prevention. Histologically, the majority of cervical cancers are squamous cell carcinomas (~80%), followed by adenocarcinomas and adenosquamous carcinomas. The World Health Organization now distinguishes between HPV-associated and HPV-independent tumors, with the latter comprising roughly 5% of cases — often displaying worse outcomes and distinct molecular profiles — although current treatment strategies do not yet differ based on HPV status. Here are five things to know about Cervical Cancer. 1. HPV vaccination and screening remain the most powerful tools for prevention. Persistent infection with oncogenic HPV types, particularly HPV 16 and 18, is responsible for over 95% of cervical cancers. Screening and vaccination efforts have significantly reduced cervical cancer incidence in countries with established programs. According to 2018 recommendations from the United States Preventive Services Task Force, women aged 21-29 should undergo cervical cytology (Pap smear) every 3 years, while those aged 30-65 may choose between cytology every 3 years, high-risk HPV testing every 5 years, or cotesting every 5 years. In contrast, the American Cancer Society's 2020 guidelines recommend beginning screening at age 25 with HPV testing as the preferred method. No routine screening is recommended for women younger than 21, older than 65, or those who have undergone a hysterectomy for benign reasons. HPV vaccination has transformed cervical cancer prevention. Vaccination before the age of 17 has been shown to reduce cervical cancer incidence by nearly 90%, and growing evidence supports that a single dose may be as effective as a full series, which could simplify implementation in low-resource settings. 2. At-home HPV testing is a breakthrough in improving access. To expand screening to underserved populations, the FDA approved clinician-supervised self-collected HPV testing in 2024 and fully at-home HPV testing in 2025. These regulatory changes represent a major shift in cervical cancer screening accessibility. Clinical trials have demonstrated that the sensitivity of at-home HPV testing of ~95% is equivalent to that of clinician-collected samples. This development is especially important for increasing screening rates in medically underserved communities, including individuals with limited access to healthcare, cultural stigma surrounding pelvic exams, or logistical barriers to in-person visits. By reducing these obstacles, at-home HPV testing has the potential to improve early detection, narrow disparities, and prevent progression to advanced cervical cancer among those most at risk. 3. HPV is the primary risk factor, but others contribute to disease development. While infection with high-risk HPV is a necessary precursor to most cervical cancers, not all women with HPV will develop cancer. Additional factors can influence progression from transient infection to persistent infection, dysplasia, and ultimately malignancy. Tobacco use is among the most well-established risk factors, doubling the risk of squamous cell carcinoma by impairing local immune defenses in the cervix. Immunosuppression, especially in individuals with the human immunodeficiency virus, markedly increases the risk of persistent HPV infection and cervical dysplasia. Other contributing factors include chronic chlamydia infection, long-term use of oral contraceptives, having three or more full-term pregnancies, early age at first childbirth, poor diet lacking in fruits and vegetables, and exposure to diethylstilbestrol in utero. Lower socioeconomic status is consistently associated with higher cervical cancer incidence and worse outcomes, largely due to reduced access to screening and timely care. Though uncommon, a subset of cervical cancers (3%-8%) are not associated with HPV and tend to present at older ages, potentially with more aggressive biology. 4. Symptoms often appear late, making screening critical. Most early cervical cancers and pre-cancerous lesions are asymptomatic, which is why regular screening is vital for early detection. When symptoms do occur, they often include abnormal vaginal bleeding, such as post-coital or intermenstrual bleeding, watery or malodorous vaginal discharge, pelvic pain, and dyspareunia. As the disease advances, more severe symptoms may develop, including urinary symptoms, lower abdominal pressure, hematuria, and hematochezia depending on the site of metastasis. Diagnosis is initiated with colposcopy and biopsy following abnormal screening results. Biopsies may include punch biopsy, endocervical curettage, or cone biopsy depending on lesion size and location. Once cancer is confirmed, staging typically involves pelvic examination, imaging such as MRI or PET-CT, and sometimes examination under anesthesia. Cervical cancer is staged using the International Federation of Gynecology and Obstetrics system, which incorporates clinical and radiologic findings to guide treatment decisions. Lack of participation in cervical cancer screening is a key reason for late-stage diagnosis, highlighting the critical need to improve screening uptake and address missed opportunities for early detection. 5. Treatment is stage-specific and increasingly personalized. Treatment of cervical cancer depends on disease stage, type of cervical cancer, patient comorbidities and age, desire for fertility preservation, and whether the cancer has just been diagnosed or has recurred. For patients with microinvasive disease (stage IA1), options include cold knife conization if the depth of invasion is < 3 mm or total hysterectomy. Stages IA2-IB2 are typically managed with radical hysterectomy and pelvic lymphadenectomy, although fertility-sparing surgery such as radical trachelectomy may be considered in select patients; intracavitary radiation therapy may be considered as a palliative option for women who are not eligible for surgery or have medical contraindications to other treatments. Locally advanced disease (stages IB3-IVA) is treated with definitive chemoradiation, usually consisting of external beam radiation therapy combined with weekly cisplatin. Brachytherapy is an essential component of treatment for curative intent. Recent data suggest that induction chemotherapy before chemoradiation may improve survival outcomes in some patients, although this approach is still under investigation. For recurrent or metastatic disease, systemic therapy with or without palliative radiation is the mainstay. First-line therapy often includes a combination of platinum-based chemotherapy, paclitaxel, and the antiangiogenic agent bevacizumab. For patients with PD-L1-positive tumors, the addition of pembrolizumab, with or without bevacizumab, to chemotherapy has become standard of care based on the KEYNOTE-826 trial. In the second-line setting, options expand to include other cytotoxic agents such as topotecan, gemcitabine, or vinorelbine, as well as immunotherapy and targeted agents. In pregnancy, treatment strategies depend on cancer stage and gestational age, often balancing maternal prognosis with fetal viability.
Yahoo
3 hours ago
- Yahoo
Sugar cookies sold in 20 states recalled for potential wood contamination: See map
Sugar cookies sold in 20 states recalled for potential wood contamination: See map Hundreds of cases of sugar cookies sold at Target are being recalled for potential contamination by a "foreign material," according to a notice posted to the Food and Drug Administration's website. The voluntary recall for the Favorite Day Bakery Frosted Sugar Cookies was issued on July 22 by Give and Go Prepared Foods Corp. in Canada, according to the FDA. Favorite Day is a private label brand sold at Target. In total, 803 cases are being recalled due to the potential foreign contamination. The cookies, which could potentially contain wood, were distributed across 20 different states and Washington, D.C., the notice stated. The recall is classified as a Class II recall, meaning the product "may cause temporary or medically reversible adverse health consequences," according to the FDA. A press release was not issued for the recall, but as of Sunday, Aug. 10, the recall is ongoing. Target did not immediately respond to a request for comment from USA TODAY on Aug. 10. Where were the recalled sugar cookies sold? The cookies were sold in the following states and districts: Connecticut District of Columbia Delaware Illinois Indiana Kentucky Massachusetts Maryland Maine Michigan Montana North Carolina New Hampshire New Jersey New York Ohio Pennsylvania Rhode Island Tennessee Virginia Vermont How to tell if you purchased the recalled product The recalled cookies, Favorite Day Bakery Frosted Sugar Cookies, 10 count, were distributed by Target and produced in Canada. The cookies are a part of Lot 25195, with the UPC number 85239-41250 3. The packs of cookies have varying Best By Dates, as that is determined by when the retailer removed the cookies from the freezers, according to the notice. Julia is a trending reporter for USA TODAY. Connect with her on LinkedIn, X, Instagram and TikTok: @juliamariegz, or email her at jgomez@ This article originally appeared on USA TODAY: Favorite Day sugar cookies sold at Target in 20 states recalled Solve the daily Crossword
Yahoo
5 hours ago
- Yahoo
Outrage as baby dies after genital mutilation in The Gambia
The death of a one-month-old baby girl who was the victim of female genital mutilation (FGM) in The Gambia has sparked widespread outrage. The baby was rushed to a hospital in the capital, Banjiul, after she developed severe bleeding, but was pronounced dead on arrival, police said. Although an autopsy is still being conducted to establish the cause of her death, many people have linked it to FGM, or female circumcision, a cultural practice outlawed in the West African state. "Culture is no excuse, tradition is no shield, this is violence, pure and simple," a leading non-governmental organisation, Women In Leadership and Liberation (WILL), said in a statement. Two women had been arrested for their alleged involvement in the baby's death, police said. The MP for the Kombo North District where the incident happened emphasised the need to protect children from harmful practices that rob them of their health, dignity, and life. "The loss of this innocent child must not be forgotten. Let it mark a turning-point and a moment for our nation to renew its unwavering commitment to protecting every child's right to life, safety, and dignity," Abdoulie Ceesay said. FGM is the deliberate cutting or removal of a female's external genitalia. The most frequently cited reasons for carrying it out are social acceptance, religious beliefs, misconceptions about hygiene, a means of preserving a girl or woman's virginity, making her "marriageable", and enhancing male sexual pleasure. The Gambia is among the 10 countries with the highest rates of FGM, with 73% of women and girls aged 15 to 49 having undergone the procedure, with many doing so before the age of six years. 'I wanted my clitoris back' - FGM survivor WILL founder Fatou Baldeh told the BBC that there was an increase in FGM procedures being performed on babies in The Gambia. "Parents feel that if they cut their girls when they're babies, they heal quicker, but also, because of the law, they feel that if they perform it at such a young age, it's much easier to disguise, so that people don't know," she said. FGM has been outlawed in The Gambia since 2015, with fines and jail terms of up to three years for perpetrators, and life sentences if a girl dies as a result. However, there have only been two prosecutions and one conviction, in 2023. A strong lobby group has emerged to demand the decriminalisation of FGM, but legislation aimed at repealing the ban was voted down in parliament last year. FGM is banned in more than 70 countries globally but continues to be practised particularly in Africa's Muslim-majority countries, such as The Gambia. You may also be interested in: What is FGM, where does it happen and why? FGM survivor refuses to let mutilation define her life 'Why I broke the law to be circumcised aged 26' Go to for more news from the African continent. Follow us on Twitter @BBCAfrica, on Facebook at BBC Africa or on Instagram at bbcafrica BBC Africa podcasts Focus on Africa This Is Africa
